Monovo (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Monovo, is a corticosteroid presented as a topical formulation for skin use. It is prescribed to reduce inflammation and relieve symptoms in various dermatologic conditions such as atopic dermatitis, psoriasis, seborrheic dermatitis and contact dermatitis.

GNH USA supplies Monovo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. It holds regulatory approvals across multiple regions, ensuring consistent product availability.

Mometasone Furoate is used topically to manage inflammatory skin disorders. - Atopic dermatitis: reduces inflammation, itching and scaling associated with the condition. - Psoriasis: decreases plaque formation and erythema in affected areas. - Seborrheic dermatitis: controls redness and flaking on the scalp and face. - Contact dermatitis: alleviates allergic skin reactions and irritation.

Topical application of Mometasone Furoate may be associated with local adverse reactions.

Common Side Effects: - Burning sensation at the application site. - Itching or mild irritation. - Dryness or peeling of the skin. - Redness or erythema. - Folliculitis or acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Hypopigmentation or discoloration of treated areas. - Secondary bacterial, fungal or viral infection. - Systemic corticosteroid effects such as adrenal suppression. - Allergic contact dermatitis or severe hypersensitivity reaction.

When prescribing or using Monovo, several precautions should be observed to minimize risks. - Duration of treatment: limit use to the shortest period necessary to control symptoms. - Application area: avoid extensive or occlusive coverage, especially on large body surface areas. - Infected skin: do not apply on active bacterial, fungal or viral skin infections. - Children: use with caution in pediatric patients, monitoring for growth‑related effects. - Pregnancy and lactation: safety has not been established; assess risk versus benefit. - Store at room temperature: keep in the original container, protect from moisture and light.

Mometasone Furoate may interact with other agents, influencing efficacy or safety.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: may increase risk of systemic side effects such as adrenal suppression. - Live vaccines: topical steroid use can diminish immune response to vaccination.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topical agents: may alter skin barrier and affect absorption. - Other topical corticosteroids: combined use can enhance local adverse effects. - CYP3A4 inhibitors applied to the same area: potential increase in local drug concentration.